---
document_datetime: 2025-12-02 06:17:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/immunogam.html
document_name: immunogam.html
version: success
processing_time: 0.098763
conversion_datetime: 2025-12-27 21:18:54.57916
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# ImmunoGam

[RSS](/en/individual-human-medicine.xml/67005)

##### Withdrawn

This medicine's authorisation has been withdrawn

human hepatitis B immunoglobulin Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 March 2010 the European Commission granted a marketing authorisation for the whole European Union to Cangene Europe Limited for ImmunoGam (Human Hepatitis B Immunoglobulin).

ImmunoGam (Human Hepatitis B Immunoglobulin) is a solution for injection that contains the active substance human hepatitis B immunoglobulin. ImmunoGam was indicated for the prevention of hepatitis B virus recurrence after liver transplantation in HBsAg-positive patients and immunoprophylaxis of hepatitis B.

On 17 August 2010, the marketing authorisation holder (MAH) responsible for ImmunoGam has requested the voluntary withdrawal of ImmuoGam from the Community Register.

The European Commission adopted the decision to withdraw, at the holder's request, the marketing authorisation granted by Decision C(2010)1810 for ImmunoGam (Human Hepatitis B Immunoglobulin) on 6 September 2010.

ImmunoGam : EPAR - Summary for the public

English (EN) (289.91 KB - PDF)

**First published:** 07/05/2010

**Last updated:** 26/01/2011

[View](/en/documents/overview/immunogam-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-1)

български (BG) (446.49 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/bg/documents/overview/immunogam-epar-summary-public_bg.pdf)

español (ES) (352.16 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/es/documents/overview/immunogam-epar-summary-public_es.pdf)

čeština (CS) (352.2 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/cs/documents/overview/immunogam-epar-summary-public_cs.pdf)

dansk (DA) (291.64 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/da/documents/overview/immunogam-epar-summary-public_da.pdf)

Deutsch (DE) (292.91 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/de/documents/overview/immunogam-epar-summary-public_de.pdf)

eesti keel (ET) (290.68 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/et/documents/overview/immunogam-epar-summary-public_et.pdf)

ελληνικά (EL) (392.04 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/el/documents/overview/immunogam-epar-summary-public_el.pdf)

français (FR) (353.07 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fr/documents/overview/immunogam-epar-summary-public_fr.pdf)

italiano (IT) (291.83 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/it/documents/overview/immunogam-epar-summary-public_it.pdf)

latviešu valoda (LV) (358.07 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lv/documents/overview/immunogam-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (321.31 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lt/documents/overview/immunogam-epar-summary-public_lt.pdf)

magyar (HU) (343.62 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/hu/documents/overview/immunogam-epar-summary-public_hu.pdf)

Malti (MT) (351.08 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/mt/documents/overview/immunogam-epar-summary-public_mt.pdf)

Nederlands (NL) (292.21 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/nl/documents/overview/immunogam-epar-summary-public_nl.pdf)

polski (PL) (351.45 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pl/documents/overview/immunogam-epar-summary-public_pl.pdf)

português (PT) (352.8 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pt/documents/overview/immunogam-epar-summary-public_pt.pdf)

română (RO) (321.65 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/ro/documents/overview/immunogam-epar-summary-public_ro.pdf)

slovenčina (SK) (409.63 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sk/documents/overview/immunogam-epar-summary-public_sk.pdf)

slovenščina (SL) (345.68 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sl/documents/overview/immunogam-epar-summary-public_sl.pdf)

Suomi (FI) (299 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fi/documents/overview/immunogam-epar-summary-public_fi.pdf)

svenska (SV) (350.06 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sv/documents/overview/immunogam-epar-summary-public_sv.pdf)

## Product information

ImmunoGam : EPAR - Product Information

English (EN) (802.72 KB - PDF)

**First published:** 07/05/2010

**Last updated:** 26/01/2011

[View](/en/documents/product-information/immunogam-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-923)

български (BG) (1.31 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/bg/documents/product-information/immunogam-epar-product-information_bg.pdf)

español (ES) (835.76 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/es/documents/product-information/immunogam-epar-product-information_es.pdf)

čeština (CS) (1.17 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/cs/documents/product-information/immunogam-epar-product-information_cs.pdf)

dansk (DA) (848.99 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/da/documents/product-information/immunogam-epar-product-information_da.pdf)

Deutsch (DE) (778.51 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/de/documents/product-information/immunogam-epar-product-information_de.pdf)

eesti keel (ET) (882.81 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/et/documents/product-information/immunogam-epar-product-information_et.pdf)

ελληνικά (EL) (1.36 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/el/documents/product-information/immunogam-epar-product-information_el.pdf)

français (FR) (430.43 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fr/documents/product-information/immunogam-epar-product-information_fr.pdf)

italiano (IT) (904.43 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/it/documents/product-information/immunogam-epar-product-information_it.pdf)

latviešu valoda (LV) (1.17 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lv/documents/product-information/immunogam-epar-product-information_lv.pdf)

lietuvių kalba (LT) (983.95 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lt/documents/product-information/immunogam-epar-product-information_lt.pdf)

magyar (HU) (1.15 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/hu/documents/product-information/immunogam-epar-product-information_hu.pdf)

Malti (MT) (1.17 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/mt/documents/product-information/immunogam-epar-product-information_mt.pdf)

Nederlands (NL) (933.16 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/nl/documents/product-information/immunogam-epar-product-information_nl.pdf)

polski (PL) (1.19 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pl/documents/product-information/immunogam-epar-product-information_pl.pdf)

português (PT) (852.54 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pt/documents/product-information/immunogam-epar-product-information_pt.pdf)

română (RO) (1010.02 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/ro/documents/product-information/immunogam-epar-product-information_ro.pdf)

slovenčina (SK) (1.18 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sk/documents/product-information/immunogam-epar-product-information_sk.pdf)

slovenščina (SL) (1.15 MB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sl/documents/product-information/immunogam-epar-product-information_sl.pdf)

Suomi (FI) (785.34 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fi/documents/product-information/immunogam-epar-product-information_fi.pdf)

svenska (SV) (834.16 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sv/documents/product-information/immunogam-epar-product-information_sv.pdf)

06/09/2010

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

ImmunoGam : EPAR - All Authorised presentations

English (EN) (235.48 KB - PDF)

**First published:** 07/05/2010

**Last updated:** 26/01/2011

[View](/en/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-985)

български (BG) (283.25 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/bg/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_bg.pdf)

español (ES) (238.05 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/es/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_es.pdf)

čeština (CS) (274.55 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/cs/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (237.64 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/da/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (237.2 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/de/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (237.72 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/et/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (282.49 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/el/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_el.pdf)

français (FR) (237.62 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fr/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (237.34 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/it/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (276.82 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lv/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (265.43 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/lt/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (260.74 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/hu/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (275.64 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/mt/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (237.09 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/nl/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_nl.pdf)

polski (PL) (277.2 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pl/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_pl.pdf)

português (PT) (238.01 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/pt/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_pt.pdf)

română (RO) (265.44 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/ro/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (275.1 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sk/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (246.73 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sl/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (237.19 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/fi/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (237.91 KB - PDF)

**First published:**

07/05/2010

**Last updated:**

26/01/2011

[View](/sv/documents/all-authorised-presentations/immunogam-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine ImmunoGam Active substance human hepatitis B immunoglobulin International non-proprietary name (INN) or common name human hepatitis B immunoglobulin Therapeutic area (MeSH)

- Immunization, Passive
- Hepatitis B

Anatomical therapeutic chemical (ATC) code J06BB04

### Pharmacotherapeutic group

Specific immunoglobulins

### Therapeutic indication

Immunoprophylaxis of Hepatitis B

- In case of accidental exposure in non-immunised subjects (including persons whose vaccination is

- In haemodialysed patients, until vaccination has become effective.

- In the newborn of a hepatitis B virus carrier-mother.

- In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.

Consideration should also be given to other official guidance on the appropriate use of human hepatitis B immunoglobulin for intramuscular use.

## Authorisation details

EMA product number EMEA/H/C/001055 Marketing authorisation holder

Cangene Europe Limited

Cangene Europe Ltd. Parkshot House 5 Kew Road Richmond, Surrey TW9 2PR United Kingdom

Marketing authorisation issued 16/03/2010 Withdrawal of marketing authorisation 06/09/2010

## Assessment history

## Initial marketing authorisation documents

ImmunoGam : EPAR - Public assessment report

English (EN) (678.63 KB - PDF)

**First published:** 07/05/2010

**Last updated:** 26/01/2011

[View](/en/documents/assessment-report/immunogam-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for ImmunoGam

Adopted

Reference Number: EMA/CHMP/831707/2009

English (EN) (32.96 KB - PDF)

**First published:** 17/12/2009

**Last updated:** 17/12/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-immunogam_en.pdf)

**This page was last updated on** 26/01/2011

## Share this page

[Back to top](#main-content)